Filing Details

Accession Number:
0001725160-21-000222
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-11-12 16:38:22
Reporting Period:
2021-11-10
Accepted Time:
2021-11-12 16:38:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1725160 Zentalis Pharmaceuticals Inc. ZNTL Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1807484 D. Kevin Bunker C/O Zentalis Pharmaceuticals, Inc.
530 Seventh Avenue, Suite 2201
New York NY 10018
Chief Operating Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-11-09 240,000 $0.00 755,067 No 5 G Direct
Common Stock Acquisiton 2021-11-09 240,000 $0.00 240,000 No 5 G Indirect See Footnote
Common Stock Disposition 2021-11-10 10,000 $78.15 230,000 No 4 S Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 5 G Direct
No 5 G Indirect See Footnote
No 4 S Indirect See Footnote
Footnotes
  1. Represents shares nominally held by Sundog Ranch, Inc. on behalf of the Bunker Family Protection Trust, the sole shareholder of Sundog Ranch, Inc. The Reporting Person and his wife are the primary beneficiaries of the Bunker Family Protection Trust and the Reporting Person and his wife are also directors of Sundog Ranch, Inc. The Reporting Person disclaims beneficial ownership of the securities held by Sundog Ranch, Inc. except to the extent of his pecuniary interest therein, if any.
  2. The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 16, 2021.